AHN-GOOK PHARMACEUTICAL Co., Ltd.

안국약품(주) · KOSDAQ: 001540 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name: 안국약품(주)
Market / ticker: KOSDAQ · 001540
Industry: Pharmaceuticals and medicinal chemicals
Established: 1959-02-12
Fiscal year ends: December
Website: www.ahn-gook.com
DART corp code: 00139205
Latest revenue: ₩306.9B (FY2025)

Items worth checking

high

Production halt disclosed — filed 2026-05-08.

Financial summary

KRW	FY2023	FY2024	FY2025
Revenue	₩233.7B	₩271.1B	₩306.9B
Operating income	₩5.1B	₩6.7B	₩9.8B
Net income	₩998M	₩16.3B	₩7.3B
Total assets	₩238.6B	₩302.5B	₩311.0B
Total liabilities	₩86.9B	₩137.8B	₩144.7B
Total equity	₩151.7B	₩164.7B	₩166.3B
Share capital	₩6.5B	₩6.5B	₩6.5B

Consolidated statements · FY2025 operating margin 3.2% · liabilities to equity 87% · Annual report FY2025 (Korean original)

Auditor opinions

Period	Auditor	Opinion
Term 68 (current)	대주회계법인	Unqualified
Term 67 (prior)	대주회계법인	Unqualified
Term 66 (two years prior)	대주회계법인	Unqualified

Largest shareholder history

Date	Largest shareholder (Korean)	Stake	Cause (Korean)
2016년 12월 23일	어진	—	—
2022년 12월 20일	어진	—	상속

Recent filings

Date	Filing	Original
2026-09-11	Large shareholding (5%+) report	DART
2026-08-14	Half-year report (2026.06)	DART
2026-07-14	New facility investment	DART
2026-06-30	Large shareholding (5%+) report	DART
2026-06-05	Large shareholding (5%+) report	DART
2026-06-05	생산재개(자율공시)	DART
2026-05-14	Quarterly report (2026.03)	DART
2026-05-08	Production halted	DART
2026-04-17	Large shareholding (5%+) report	DART
2026-03-27	Corporate value-up plan (voluntary)	DART
2026-03-26	Annual general meeting results	DART
2026-03-18	Annual report (2025.12)	DART
2026-03-18	Audit report submitted	DART
2026-02-27	Large shareholding (5%+) report	DART
2026-02-27	Amended: Proxy solicitation reference document	DART
2026-02-27	Amended: Notice of shareholders meeting	DART
2026-02-26	Proxy solicitation reference document	DART
2026-02-26	Notice of shareholders meeting	DART
2026-02-25	Cash / in-kind dividend decision	DART
2026-02-25	Resolution to convene shareholders meeting	DART

Showing the 20 most recent of 29 filings. The full brief lists all of them.

Full brief on AHN-GOOK PHARMACEUTICAL Co., Ltd. — $39

Every filing from the last 12 months in English, not just the 20 most recent — each linked to its Korean original
Latest half-year and quarterly figures on top of the three annual years, plus the full auditor and largest-shareholder history
Any KOSPI, KOSDAQ or KONEX company, not just the ones listed here — delivered as a private link the moment payment clears

Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Pharmaceuticals and medicinal chemicals

Aprogen Biologics Inc. KOSPI 003060
Aprogen, Inc KOSPI 007460
Boryung Corporation KOSPI 003850
BUKWANG PHARMACEUTICAL IND CO.,LTD KOSPI 003000
CHONGKUNDANG HOLDINGS CORP. KOSPI 001630
DAEWON PHARMACEUTICAL CO.,LTD KOSPI 003220

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.